Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.

Gratias EJ, Jennings LJ, Anderson JR, Dome JS, Grundy P, Perlman EJ.

Cancer. 2013 Nov 1;119(21):3887-94. doi: 10.1002/cncr.28239. Epub 2013 Aug 26.

PMID:
23983061
[PubMed - indexed for MEDLINE]
2.

Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group.

Grundy PE, Green DM, Dirks AC, Berendt AE, Breslow NE, Anderson JR, Dome JS.

Pediatr Blood Cancer. 2012 Oct;59(4):631-5. doi: 10.1002/pbc.24123. Epub 2012 Mar 15.

PMID:
22422736
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Extending the phenotypes associated with DICER1 mutations.

Foulkes WD, Bahubeshi A, Hamel N, Pasini B, Asioli S, Baynam G, Choong CS, Charles A, Frieder RP, Dishop MK, Graf N, Ekim M, Bouron-Dal Soglio D, Arseneau J, Young RH, Sabbaghian N, Srivastava A, Tischkowitz MD, Priest JR.

Hum Mutat. 2011 Dec;32(12):1381-4. doi: 10.1002/humu.21600. Epub 2011 Oct 11.

PMID:
21882293
[PubMed - indexed for MEDLINE]
4.

The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group.

Hamilton TE, Ritchey ML, Haase GM, Argani P, Peterson SM, Anderson JR, Green DM, Shamberger RC.

Ann Surg. 2011 May;253(5):1004-10. doi: 10.1097/SLA.0b013e31821266a0.

PMID:
21394016
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.

Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S, Barfoot R, Burke A, Chisholm J, Hewitt M, Jenkinson H, King D, Morland B, Pizer B, Prescott K, Saggar A, Side L, Traunecker H, Vaidya S, Ward P, Futreal PA, Vujanic G, Nicholson AG, Sebire N, Turnbull C, Priest JR, Pritchard-Jones K, Houlston R, Stiller C, Stratton MR, Douglas J, Rahman N.

J Med Genet. 2011 Apr;48(4):273-8. doi: 10.1136/jmg.2010.083790. Epub 2011 Jan 25.

PMID:
21266384
[PubMed - indexed for MEDLINE]
6.

WTX mutations can occur both early and late in the pathogenesis of Wilms tumour.

Fukuzawa R, Holman SK, Chow CW, Savarirayan R, Reeve AE, Robertson SP.

J Med Genet. 2010 Nov;47(11):791-4. doi: 10.1136/jmg.2010.080663. Epub 2010 Aug 2.

PMID:
20679664
[PubMed - indexed for MEDLINE]
7.

Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Williams RD, Al-Saadi R, Chagtai T, Popov S, Messahel B, Sebire N, Gessler M, Wegert J, Graf N, Leuschner I, Hubank M, Jones C, Vujanic G, Pritchard-Jones K; Children's Cancer and Leukaemia Group; SIOP Wilms' Tumour Biology Group.

Clin Cancer Res. 2010 Apr 1;16(7):2036-45. doi: 10.1158/1078-0432.CCR-09-2890. Epub 2010 Mar 23.

PMID:
20332316
[PubMed - indexed for MEDLINE]
Free Article
8.

FDG positron emission tomography/computed tomography studies of Wilms' tumor.

Moinul Hossain AK, Shulkin BL, Gelfand MJ, Bashir H, Daw NC, Sharp SE, Nadel HR, Dome JS.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1300-8. doi: 10.1007/s00259-010-1396-2. Epub 2010 Mar 4.

PMID:
20204356
[PubMed - indexed for MEDLINE]
9.

Phenotypic discordance upon paternal or maternal transmission of duplications of the 11p15 imprinted regions.

Bliek J, Snijder S, Maas SM, Polstra A, van der Lip K, Alders M, Knegt AC, Mannens MM.

Eur J Med Genet. 2009 Nov-Dec;52(6):404-8. doi: 10.1016/j.ejmg.2009.08.006. Epub 2009 Sep 6.

PMID:
19735747
[PubMed - indexed for MEDLINE]
10.

Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis.

Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia-Miñaur S, Bohring A, Lacombe D, Stewart F, Fiskerstrand T, Bindoff L, Berland S, Adès LC, Tchan M, David A, Wilson LC, Hennekam RC, Donnai D, Mansour S, Cormier-Daire V, Robertson SP.

Nat Genet. 2009 Jan;41(1):95-100. doi: 10.1038/ng.270. Epub 2008 Dec 14.

PMID:
19079258
[PubMed - indexed for MEDLINE]
11.

Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.

Scott RH, Douglas J, Baskcomb L, Huxter N, Barker K, Hanks S, Craft A, Gerrard M, Kohler JA, Levitt GA, Picton S, Pizer B, Ronghe MD, Williams D; Factors Associated with Childhood Tumours (FACT) Collaboration, Cook JA, Pujol P, Maher ER, Birch JM, Stiller CA, Pritchard-Jones K, Rahman N.

Nat Genet. 2008 Nov;40(11):1329-34. doi: 10.1038/ng.243. Epub 2008 Oct 5.

PMID:
18836444
[PubMed - indexed for MEDLINE]
12.

Familial Beckwith-Wiedemann syndrome due to CDKN1C mutation manifesting with recurring omphalocele.

Percesepe A, Bertucci E, Ferrari P, Lugli L, Ferrari F, Mazza V, Forabosco A.

Prenat Diagn. 2008 May;28(5):447-9. doi: 10.1002/pd.1991. No abstract available.

PMID:
18395877
[PubMed - indexed for MEDLINE]
13.

Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.

Perotti D, Gamba B, Sardella M, Spreafico F, Terenziani M, Collini P, Pession A, Nantron M, Fossati-Bellani F, Radice P.

Oncogene. 2008 Jul 31;27(33):4625-32. doi: 10.1038/onc.2008.93. Epub 2008 Apr 7.

PMID:
18391980
[PubMed - indexed for MEDLINE]
14.

The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor. The St Jude Children's Research Hospital experience: 1999-2006.

Davidoff AM, Giel DW, Jones DP, Jenkins JJ, Krasin MJ, Hoffer FA, Williams MA, Dome JS.

Cancer. 2008 May 1;112(9):2060-70. doi: 10.1002/cncr.23406.

PMID:
18361398
[PubMed - indexed for MEDLINE]
Free Article
15.

Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.

Ruteshouser EC, Robinson SM, Huff V.

Genes Chromosomes Cancer. 2008 Jun;47(6):461-70. doi: 10.1002/gcc.20553.

PMID:
18311776
[PubMed - indexed for MEDLINE]
16.

Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation.

Scott RH, Douglas J, Baskcomb L, Nygren AO, Birch JM, Cole TR, Cormier-Daire V, Eastwood DM, Garcia-Minaur S, Lupunzina P, Tatton-Brown K, Bliek J, Maher ER, Rahman N.

J Med Genet. 2008 Feb;45(2):106-13. doi: 10.1136/jmg.2007.053207. Epub 2007 Oct 15.

PMID:
18245390
[PubMed - indexed for MEDLINE]
17.

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.

Malogolowkin M, Cotton CA, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PR, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D; National Wilms Tumor Study Group.

Pediatr Blood Cancer. 2008 Feb;50(2):236-41.

PMID:
17539021
[PubMed - indexed for MEDLINE]
18.

An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.

Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA.

Science. 2007 Feb 2;315(5812):642-5. Epub 2007 Jan 4.

PMID:
17204608
[PubMed - indexed for MEDLINE]
Free Article
19.

Beckwith-Wiedemann syndrome: multiple molecular mechanisms.

Enklaar T, Zabel BU, Prawitt D.

Expert Rev Mol Med. 2006 Jul 17;8(17):1-19. Review.

PMID:
16842655
[PubMed - indexed for MEDLINE]
20.

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.

Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM.

J Clin Oncol. 2006 May 20;24(15):2352-8.

PMID:
16710034
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk